Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 151

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 151
---
 align='center'>EXPENSES OF THE OFFERING</div>

The following table sets forth the expenses payable by us in connection
with the sale and distribution of the securities being registered hereby, other than placement agent fees, discounts and commissions.
All amounts shown, other than the SEC registration fee and FINRA filing fee, are estimates:

| SEC registration fee    | $ |  14,231 |
| FINRA filing fee        |   |   3,088 |
| Printing expenses       |   |   5,000 |
| Accounting services     |   |  50,000 |
| Legal fees and expenses |   | 250,000 |
| Miscellaneous           |   |  10,000 |
| Total                   | $ | 332,319 |

| 90 |

<div align='center'>Biodexa Pharmaceuticals PLC

Up to 4,422,604 Units, Each Unit Consisting of One American Depositary Share

and Two Series L Warrants, Each to Purchase One American Depositary Share

or

Up to 4,422,604Pre-Funded Units, Each Pre-Funded Unit Consisting of One Pre-Funded Warrant to Purchase One American Depositary Share

and Two Series L Warrants, Each to Purchase One American Depositary Share

Up to 4,422,604 American Depositary Shares Representing 442,260,400,000 Ordinary Shares

Up to 4,422,604 American Depositary Shares Representing 442,260,400,000 Ordinary Shares Underlying the Pre-Funded Warrants

Up to 8,845,208American Depositary Shares Representing 884,520,800,000 Ordinary Shares Underlying the Series L Warrants

Up to 221,130 American Depositary Shares Representing 22,113,000,000 Underlying the Placement Agent Warrants

PRELIMINARY PROSPECTUS

Sole Placement Agent

MAXIM GROUP LLC

, 2025</div>

| 91 |

<div align='center'>PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

| Item 6. | Indemnification of Directors and Officers. |

The Registrant’s articles
of association provide that, subject to the Companies Act, every person who is or was at any time a director, alternate director, or former
director of the Registrant or of any of its subsidiaries may be indemnified out of the assets of the Registrant against all costs, charges